CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-26 | NEIL GARRY ARTHUR Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +260,000 | 260,000 | ||
| 2021-01-26 | Harrell James Archie Jr Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2021-01-08 | ARMISTICE CAPITAL, LLC Director | Purchase | +2,500,000 | $2.60 | $6.5M | 32,634,285 |
| 2021-01-08 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 32,634,285 | ||
| 2021-01-04 | COLA MICHAEL F Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +64,798 | 64,798 | ||
| 2020-12-31 | Miller Joseph M Director | Grant or award · Stock Option (Right to Buy) | +5,472 | 5,472 | ||
| 2020-12-31 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +7,216 | 7,216 | ||
| 2020-12-31 | Gutry Phil Director | Grant or award · Stock Option (Right to Buy) | +3,877 | 3,877 | ||
| 2020-12-31 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +4,919 | 4,919 | ||
| 2020-12-31 | Bruhn Suzanne Louise Director | Grant or award · Stock Option (Right to Buy) | +4,254 | 4,254 | ||
| 2020-12-10 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +171 | $2.28 | $390 | 28,180 |
| 2020-12-10 | Sullivan Christopher Ryan Interim CFO | Purchase | +5,095 | $2.28 | $12K | 8,049 |
| 2020-12-10 | NEIL GARRY ARTHUR Chief Scientific Officer | Purchase | +3,599 | $2.28 | $8K | 77,680 |
| 2020-12-03 | ARMISTICE CAPITAL, LLC Director | Purchase | +20,000 | $2.44 | $49K | 30,134,285 |
| 2020-12-03 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 30,134,285 | ||
| 2020-11-25 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +15,000 | $2.39 | $36K | 30,114,285 |
| 2020-11-25 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +0 | 30,114,285 | ||
| 2020-11-24 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +47,733 | $2.40 | $115K | 30,099,285 |
| 2020-11-24 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +0 | 30,099,285 | ||
| 2020-11-23 | ARMISTICE CAPITAL, LLC 10% owner | Purchase | +37,267 | $2.32 | $86K | 30,051,552 |
Page 19 of 25 · 500 trades